Details for 2018159324

Up to date per 02.04.2026

Actions

Title / Product Name

BINDUNGSFUSIONSPROTEINE, BINDUNGSFUSIONSPROTEINARZNEIMITTELKONJUGATE, XTEN-ARZNEIMITTELKONJUGATE SOWIE VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018159324

EP Publication Number

3372617

E-Number

1706264

Language

PCT Number

Publication Date

12.09.2018 A

24.07.2024 B1

Registration Date

24.07.2024

AT Publication Date

15.08.2024

Application Date

01.04.2011

Registration Number

Priorities

02.04.2010

341720 P

08.04.2010

341996 P

IPC

C07K 19/00 20060101AFI20181108BHEP

Maximum Duration of Protection

01.04.2031

Owner

Amunix Pharmaceuticals, Inc.2 Tower Pl 1100 South San Francisco, CA 94080-1826US

Representative

No representatives present

Inventor

Schellenberger, Volker914 Moreno Ave. Palo Alto, CA 94303US

Silverman, Joshua27791 Edgerton Rd Los Altos Hills, CA 94022US

Wang, Chia-wei1449 David Lane Milpitas, CA 95035US

Spink, Benjamin379 Northam Ave. San Carlos, CA 94070US

Stemmer, Willem P.- deceasedUS

Alters, Susan E.3372 Kipling St. Palo Alto, CA 94306US